Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.9 USD | +0.95% | +0.26% | -8.42% |
May. 10 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
May. 08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.42% | 1.44B | |
+37.78% | 723B | |
+31.13% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.51% | 244B | |
-4.62% | 208B | |
+10.04% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Raymond James Initiates Pacira BioSciences With Outperform Rating, Price Target is $42